TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 1 | -2 | 1 | -14 | -31 | 0 | 0 | -12 |
| S | %wins | 100 | 0 | 100 | 100 | 75 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/2/23 18:15 | 5/1/23 | NERV | Minerva Neurosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Luthringer Remy | MA | DO | CEO | S.m | -105 | 3.84 | 0 | -27 | -13 | 185 | D | ||||||||||||||
12/16/20 20:29 | 12/16/20 | NERV | Minerva Neurosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Luthringer Remy | MA | DO | CEO | S.d | -3 | 2.64 | 0 | -1 | 0 | 993 | D | ||||||||||||||
12/17/19 16:46 | 12/17/19 | NERV | Minerva Neurosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Luthringer Remy | MA | DO | CEO | S.d | -17 | 7.10 | 0 | -2 | 0 | 976 | D | ||||||||||||||
12/18/18 16:28 | 12/17/18 | NERV | Minerva Neurosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Luthringer Remy | MA | DO | CEO | S.d | -19 | 7.46 | 0 | -3 | 0 | 959 | D | ||||||||||||||
12/15/17 16:44 | 12/14/17 | NERV | Minerva Neurosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Luthringer Remy | MA | DO | CEO | S.d | -13 | 5.85 | 0 | -2 | 0 | 943 | D | ||||||||||||||
2/7/17 16:31 | 2/3/17 | NERV | Minerva Neurosciences, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Luthringer Remy | MA | DO | P,CEO | S.dm | -378 | 11.02 | 1 | -34 | -4 | 927 | D | 126 | 105 | -6 | 16 | -12 | 0 | 6 | 4 | -2 | 1 | -14 | -31 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |